In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee:
Time and Date: 2:00 p.m.-3:00 p.m., EST, May 11, 2015.
Place: This meeting will be accessible by teleconference. Toll-free +1 (888) 790-1864, Participant Code: 5920580.
Status: Open to the public limited only by the availability of telephone ports.
Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.
Matters for Discussion: The agenda will include a follow up discussion on the Draft Guideline for the Prevention of Surgical Site Infections. Call materials will be made available to the public no later than 2 business days before the call. If CDC is unable to post the background material on the HICPAC site prior to the meeting, the background material will be posted on HICPAC's Web site after the meeting. Background material is available at http://www.cdc.gov/hicpac.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A-31, Atlanta, Georgia 30333; Email: HICPAC@cdc.gov.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Start Printed Page 19990Prevention and the Agency for Toxic Substances and Disease Registry.
Claudette Grant, M.P.H.,
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2015-08520 Filed 4-13-15; 8:45 am]
BILLING CODE 4163-18-P